Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat in Non-Dialysis Subjects Evaluating Hemoglobin (Hgb) and Quality of Life (ASCEND-NHQ)
CompletedNCT03409107
GlaxoSmithKlineAnaemia
Start: 2018-03-05End: 2020-10-07Updated: 2024-04-02